Join Free For Buyer|Sign In

Professional Online Trade Platform for API, Preparation and Pharmaceutical Machinery and

You are here:  Home >>  News >>  Top Stories >>  Sanofi opens $77 M R&D Facility in Chengdu

Sanofi opens $77 M R&D Facility in Chengdu

July 05, 2018 By biospectrumasia

Sanofi has launched a $77 million Global R&D Operations Hub in Chengdu, which will focus on digitalization and big data analysis for clinical trials. The China R&D centre will be the third pillar of Sanofi Global Clinical Sciences and Operations, joining facilities in France and the United States.

Sanofi opens $77 M R&D Facility in Chengdu

The Hub will support clinical R&D of Sanofi's innovative drugs, managing global multi-centre clinical trials data and files. The new hub plans to recruit 300 pharma R&D staff by 2020.

Sanofi already has an R&D centre in Shanghai focusing on finding drug targets and conducting trials in common diseases such as liver diseases, diabetes, cancers, and cardiovascular diseases, in the China and Asia-Pacific region.

Diabetes drugs have long been a lynchpin of Sanofi’s business, and its major rival in this market, Novo Nordisk has also invested in R&D in China.


Editor's Note:

To apply for becoming a contributor of n-CPhI.Cn, 

welcome to send your CV and sample works to us, 



Add a comment
Click here to Login or to Register for free. You will be taken back to your selected item after Login/Registration.
More>> MarketNews
More>> Editors’Picks
More>> TopStories
More>> HotTags
Follow Us
CPhI Online Trade Platform: Worldwide|English|中国站
Customer Service:  86-400 610 1188 (9: 00-18: 00, Mon-Fri)
About Us| Contact Us| Terms of Services| Privacy Policy| Intellectual Property Statement| Links | Site Map
Copyright 2006-20 Shanghai UBM Sinoexpo International Exhibition Co Ltd (All Rights Reserved). ICP 05034851-53


live chat